These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21539819)

  • 1. Increased levels of total oxidant status and decreased activity of arylesterase in migraineurs.
    Yilmaz N; Aydin O; Yegin A; Tiltak A; Eren E
    Clin Biochem; 2011 Jul; 44(10-11):832-7. PubMed ID: 21539819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative status and serum PON1 activity in beta-thalassemia minor.
    Selek S; Aslan M; Horoz M; Gur M; Erel O
    Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with chronic adenotonsillitis.
    Koc S; Aksoy N; Bilinc H; Duygu F; Uysal IÖ; Ekinci A
    Int J Pediatr Otorhinolaryngol; 2011 Nov; 75(11):1364-7. PubMed ID: 21893350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraoxonase and arylesterase activity with oxidative status in children with thalassemia major.
    Cakmak A; Soker M; Koc A; Erel O
    J Pediatr Hematol Oncol; 2009 Aug; 31(8):583-7. PubMed ID: 19636263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraoxonase and arylesterase activities in untreated dipper and non-dipper hypertensive patients.
    Yildiz A; Gur M; Demirbag R; Yilmaz R; Akyol S; Aslan M; Erel O
    Clin Biochem; 2008 Jul; 41(10-11):779-84. PubMed ID: 18355454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum paraoxonase and arylesterase activity and oxidative status in patients with multiple sclerosis.
    Kirbas A; Kirbas S; Anlar O; Efe H; Yilmaz A
    J Clin Neurosci; 2013 Aug; 20(8):1106-9. PubMed ID: 23669169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PON1 activity and total oxidant status in patients with active pulmonary tuberculosis.
    Selek S; Cosar N; Kocyigit A; Erel O; Aksoy N; Gencer M; Gunak F; Aslan M
    Clin Biochem; 2008 Feb; 41(3):140-4. PubMed ID: 18154731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early effects of sodium valproate monotherapy on serum paraoxonase/arylesterase activities.
    Karikas GA; Schulpis KH; Bartzeliotou A; Regoutas S; Thanopoulou C; Papaevangelou V; Giannoulia-Karantana A; Papassotiriou I; Fytou-Pallikari A
    Scand J Clin Lab Invest; 2009; 69(1):31-5. PubMed ID: 19016076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the serum paraoxonase activity and oxidant/antioxidant status in patients with recurrent aphthous stomatitis.
    Bilgili SG; Ozkol H; Takci Z; Ozkol HU; Karadag AS; Aslan M
    Int J Dermatol; 2013 Oct; 52(10):1259-64. PubMed ID: 23834345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum lipid profile paraoxonase and arylesterase activities in psoriasis.
    Toker A; Kadi M; Yildirim AK; Aksoy H; Akçay F
    Cell Biochem Funct; 2009 Apr; 27(3):176-80. PubMed ID: 19330810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraoxonase and arylesterase activities in coronary artery disease.
    Gur M; Aslan M; Yildiz A; Demirbag R; Yilmaz R; Selek S; Erel O; Ozdogru I
    Eur J Clin Invest; 2006 Nov; 36(11):779-87. PubMed ID: 17032345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Diagnostic Value of Oxidative/Antioxidative Balance Parameters in Venous Thromboembolism.
    Aykal G; Güven R; Yeğin A; Ellidağ HY; Bayindir A; Yilmaz N
    Clin Lab; 2015; 61(7):769-75. PubMed ID: 26299076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
    Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraoxonase and arylesterase activities in fibromyalgia.
    Altindag O; Gur A; Calgan N; Soran N; Celik H; Selek S
    Redox Rep; 2007; 12(3):134-8. PubMed ID: 17623520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of hemodialysis membrane permeability on serum paraoxonase-1 activity and oxidative status parameters.
    Horoz M; Kiykim AA; Cimen B; Erdem A
    Artif Organs; 2011 Oct; 35(10):923-9. PubMed ID: 21517907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum paraoxonase, arylesterase activity and oxidative status in patients with obstructive sleep apnea syndrome (OSAS).
    Baysal E; Taysi S; Aksoy N; Uyar M; Celenk F; Karatas ZA; Tarakcioglu M; Bilinç H; Mumbuç S; Kanlikama M
    Eur Rev Med Pharmacol Sci; 2012 Jun; 16(6):770-4. PubMed ID: 22913209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidation of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in major depressive disorder.
    Sarandol A; Sarandol E; Eker SS; Karaagac EU; Hizli BZ; Dirican M; Kirli S
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1103-8. PubMed ID: 16716479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidant and antioxidant of arylesterase and paraoxonase as biomarkers in patients with hepatitis C virus.
    Ali EM; Shehata HH; Ali-Labib R; Esmail Zahra LM
    Clin Biochem; 2009 Sep; 42(13-14):1394-400. PubMed ID: 19538950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A monocentric pilot study of an antioxidative defense and hsCRP in pediatric patients with glycogen storage disease type IA and III.
    Kalkan Ucar S; Coker M; Sözmen E; Goksen Simsek D; Darcan S
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):383-90. PubMed ID: 19073362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with idiopathic Parkinson's disease.
    Kirbas A; Kirbas S; Cure MC; Tufekci A
    J Clin Neurosci; 2014 Mar; 21(3):451-5. PubMed ID: 24145052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.